# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charles Darwin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI003-SYN
- Date: 2026-03-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Bernard Ashworth, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for evaluation of recurrent vomiting episodes: history, symptom diary, Rome IV criteria, red flags, cannabis and substance history, anxiety and mood screens, laboratory tests, ECG, and orders for small-bowel imaging and upper endoscopy. **S**

## Objective

Hemoglobin: 14.6 g/dL; White blood cells: 6.4 10*3/uL; Platelets: 251 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Chloride: 103 mmol/L; Bicarbonate (total CO2): 25 mmol/L; Creatinine: 0.94 mg/dL; eGFR: 104 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.5 mg/dL; Albumin: 4.4 g/dL; ALT: 21 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.7 mg/dL; Lipase: 32 U/L; TSH: 1.6 mIU/L; Cortisol, morning: 14.2 ug/dL; Tissue transglutaminase IgA: 1.2 U/mL; Total IgA: 210 mg/dL; QTc (ECG): 412 ms; GAD-7: 8; PHQ-9: 6. All results are synthetic.

BP 118/74 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 71.6 kg; BMI 21.4 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluation. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Work-up between episodes: blood count, metabolic and liver panels, lipase, urinalysis, TSH, morning cortisol, celiac serology, a baseline ECG, CT enterography, and upper endoscopy. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Gastroenterology consultation to confirm the diagnosis and advise on prophylaxis, abortive treatment, and an emergency plan. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Symptom diary: date, prodrome, length and severity of each episode, triggers, medicines taken, and emergency visits. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Anxiety and mood: GAD-7 and PHQ-9 at the first visit and every three months; relaxation breathing, with cognitive behavioral therapy offered if symptoms persist. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019); Anxiety Disorders in Adults: Screening (2023) **S**
